There are currently no known outstanding effects for the The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020, Paragraph 10.
10. In regulation 26 (insertion of Schedule 13 (transitional provisions in relation to EU Exit)), in the inserted Schedule 13—U.K.
(a)for “exit day” in each place it occurs substitute “ IP completion day ”;
(b)in paragraph 3—
(i)in the heading to the paragraph, after “medicinal products” insert “ into Great Britain ”;
(ii)in sub-paragraph (1), after “that is imported” insert “ into Great Britain ”.
Commencement Information
I1Sch. 1 para. 10 in force at 31.12.2020 immediately before IP completion day, see reg. 1
Mae’r holl gynnwys ar gael dan Drwydded Llywodraeth Agored v3.0 ac eithrio ble nodir yn wahanol. Yn ychwanegol mae’r safle hwn â chynnwys sy’n deillio o EUR-Lex, a ailddefnyddiwyd dan delerau Penderfyniad y Comisiwn 2011/833/EU ar ailddefnyddio dogfennau o sefydliadau’r UE. Am ragor o wybodaeth gweler ddatganiad cyhoeddus Swyddfa Gyhoeddiadau’r UE ar ailddefnyddio.
